In the past, locally delivered MRTF/SRF inhibitors [17] and siRNA nanocomplexes [18,19] have been used to silence MRTF-B expression in fibroblasts and in animal models of glaucoma filtration surgery, showing promising results. This evidence concerns the gene MRTFB and glaucoma.